Serine-threonine kinase CK2 is highly expressed and pivotal for survival and proliferation in multiple myeloma, chronic lymphocytic leukemia and mantle cell lymphoma. The gene discussed is MARK2; the disease is B-cell chronic lymphocytic leukemia.